- Report
- February 2026
- 162 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- February 2026
- 246 Pages
Global
From €5120EUR$5,850USD£4,451GBP
- Report
- January 2026
- 197 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 181 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 181 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 198 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 193 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 184 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 191 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 196 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 193 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- January 2026
- 181 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- November 2025
- 197 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- August 2025
- 188 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- August 2025
- 188 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- August 2025
- 198 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- August 2025
- 184 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- August 2025
- 199 Pages
Global
From €3447EUR$3,939USD£2,997GBP
- Report
- September 2025
- 250 Pages
Global
From €3930EUR$4,490USD£3,416GBP
- Report
- March 2025
- 200 Pages
Global
From €3930EUR$4,490USD£3,416GBP

Macular Degeneration is a condition that affects the central part of the retina, known as the macula, which is responsible for sharp, central vision. It is the leading cause of vision loss in people over the age of 50. Optical treatments for Macular Degeneration include laser photocoagulation, photodynamic therapy, and anti-VEGF injections. Laser photocoagulation is used to reduce the risk of further vision loss by sealing off leaking blood vessels in the macula. Photodynamic therapy is used to reduce the growth of abnormal blood vessels in the macula. Anti-VEGF injections are used to reduce the growth of abnormal blood vessels and improve vision.
Companies in the Macular Degeneration market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more